The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep

The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep

The Essential Thrombocythemia is a Chronic Philadelphia-negative Myeloproliferative Neoplasm characterized by a survival curve that is only slightly worse than that of age- and sex-adjusted healthy population. The criteria for diagnosis were reviewed in 2016 by WHO. The incidence varies from 0.2 to...

Full description

Bibliographic Details
Main Authors: Vincenzo Accurso, Marco Santoro, Salvatrice Mancuso, Mariasanta Napolitano, Melania Carlisi, Marta Mattana, Chiara Russo, Alessandro Di Stefano, Davide Sirocchi, Sergio Siragusa
Format: Article
Language:English
Published: SAGE Publishing 2020-12-01
Series:Clinical Medicine Insights: Blood Disorders
Online Access:https://doi.org/10.1177/2634853520978210

Internet

https://doi.org/10.1177/2634853520978210

Similar Items